Industry representatives at the round table discussion. From left to right: Pascal Descargues (Genoskin), Dirk Weber (Aurealis Pharma) and Stefan Kaelin (Organogenesis)
Representatives from the biotech companies Organogenesis, Aurealis Pharma and Genoskin were present at the Gene2Skin Winter School. They discussed in a round table several particularities about the creation of biotech companies as well as the requirements for the transition from academia to industry. They were then involved in the best Tissue Engineering Idea pitch competition as evaluators, together with the remaining keynote lecturers. Finally, each made a presentation about their own companies.
